Patents by Inventor Karin Lövqvist

Karin Lövqvist has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds
    Publication number: 20120122933
    Abstract: The present invention relates to a novel crystalline form of esomeprazole sodium salt. Further, the present invention also relates to the use of the novel crystalline form for the treatment of gastrointestinal disorders, pharmaceutical compositions containing it as well as processes for the preparation of the novel crystalline form.
    Type: Application
    Filed: May 6, 2011
    Publication date: May 17, 2012
    Inventors: Ursula Hohlneicher, Silke Klick, Karin Lövqvist
  • Crystalline polymorphic form of glucokinase activator
    Patent number: 8093252
    Abstract: A new polymorphic form of 3-{[5-(azetidin-1-ylcarbonyl)pyrazin-2-yl]oxy}-5-{[(1S)-1-methyl-2-(methyloxy)ethyl]oxy}-N-(5-methylpyrazin-2-yl)benzamide, processes for making it and its use as an activator of glucokinase are described.
    Type: Grant
    Filed: February 15, 2010
    Date of Patent: January 10, 2012
    Assignee: AstraZeneca AB
    Inventors: Sharon Ann Bowden, David Peter Hoile, Karin Lövqvist
  • CRYSTALLINE POLYMORPHIC FORM 631
    Publication number: 20100210621
    Abstract: A new polymorphic form of 3-{[5-(azetidin-1-ylcarbonyl)pyrazin-2-yl]oxy}-5-{[(1S)-1-methyl-2-(methyloxy)ethyl]oxy}-N-(5-methylpyrazin-2-yl)benzamide, processes for making it and its use as an activator of glucokinase are described.
    Type: Application
    Filed: February 15, 2010
    Publication date: August 19, 2010
    Applicant: AstraZeneca AB
    Inventors: Sharon Ann BOWDEN, David Peter HOILE, Karin LÖVQVIST
  • Crystalline form of omeprazole
    Patent number: 7514560
    Abstract: The present invention relates to a novel crystalline form of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole, known under the generic name omeprazole. Further, the present invention also relates to the use of the novel crystalline form of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H -benzimidazole for the treatment of gastrointestinal disorders, pharmaceutical compositions containing it as well as processes for the preparation of the novel crystalline form of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole.
    Type: Grant
    Filed: May 4, 2006
    Date of Patent: April 7, 2009
    Assignee: AstraZeneca AB
    Inventors: Karin Lövqvist, Gunnel Sundén, David Noreland, Ingvar Ymén
  • 3,7-Diazabicyclo [3.3.1] formulations as anti-arrhythmic compounds
    Patent number: 7217708
    Abstract: There is provided substantially crystalline forms of 4-({3-[7-(3,3-dimethyl-2-oxobutyl) -9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl]propyl}amino)benzo-nitrile; tert-butyl 2 -{7-[3-(4-cyanoanilino)propyl]-9-oxa-3,7-diazabicyclo-[3.3.1]non-3-yl}ethylcarbamate; tert-butyl 2-{7-[4-(4-cyanophenyl)butyl]-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl}ethylcarbamate; or tert-butyl 2-{7-[2S)-3-(4-cyanophenoxy)-2-hydroxypropyl]-9-oxa-3,7-diazabicyclo-[3.3.1]non-3-yl}ethylcarbamate and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of cardiac arhythmias.
    Type: Grant
    Filed: April 12, 2002
    Date of Patent: May 15, 2007
    Assignee: Astrazeneca AB
    Inventors: Neil Barnwell, Annika Björe, Lal Cheema, David Cladingboel, Adam Herring, Karin Lövqvist
  • Crystalline form of omeprazole
    Patent number: 6384059
    Abstract: The present invention relates to a novel crystalline form of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl-1H-benzimidazole, known under the generic name omeprazole. Further, the present invention also relates to the use of the novel crystalline form of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole for the treatment of gastrointestinal disorders, pharmaceutical compositions containing it as well as processes for the preparation of the novel crystalline form of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole.
    Type: Grant
    Filed: August 15, 2000
    Date of Patent: May 7, 2002
    Assignee: AstraZëneca AB
    Inventors: Karin Lövqvist, Gunnel Sundén, David Noreland, Ingvar Ymén